Last reviewed · How we verify
NCT04835220
Trial of Oral Lenalidomide Stewardship Program for Veterans
NA trial testing Telehealth Calls in Medication Compliance in 40 participants. Status unknown.
26 March 2024
Quick facts
| Lead sponsor | W.G. Bill Hefner Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 26 March 2021 |
| Primary completion | 26 March 2024 |
| Estimated completion | 26 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Telehealth Calls
Conditions studied
- Medication Compliance — all drugs for Medication Compliance →
Sponsor
W.G. Bill Hefner Medical Center
Who can join
Eligibility, any sex, with Medication Compliance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To address the challenge of oral chemotherapy stewardship in the Veteran population, this study outlines the implementation and evaluation of a pilot program for the delivery and management of lenalidomide to increase the adherence rates. Our goal is to utilize a team-based multi-disciplinary approach using existing technological resources such as the tele-oncology program at the Salisbury VA and other VA medical centers to provide cancer care that is safe, effective, compassionate, and cost-effective. Subject will be prescribed a Lenalidomide based therapy per standard of care. Eligibility is based only on a prescription for Lenalidomide and is independent of any other concurrent treatments for myeloma. The objectives are as followed: 1. To describe the demographics and baseline clinical characteristics of veterans with newly diagnosed multiple myeloma treated with oral lenalidomide. 2. To evaluate the impact of the stewardship program (intervention) on the adherence to oral lenalidomide.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04835220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Medication Compliance
Currently open trials in the same condition.
- NCT06971627 — Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Lif · NA · recruiting
- NCT06023615 — MITIGAAT: Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants · NA · recruiting
- NCT05761847 — Pediatric Medication Therapy Management Trial · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04835220 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by W.G. Bill Hefner Medical Center
- Last refreshed: 28 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04835220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing